VBC229
/ VelaVigo
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
VBC229: A novel DLL3-targeting biparatopic T-cell engager-topoisomerase I inhibitor fusion molecule for depth and duration of response in small-cell lung cancer
(AACR 2026)
- "Abstract is embargoed at this time."
Late-breaking abstract • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor • DLL3
1 to 1
Of
1
Go to page
1